CD14 Counterregulates Lipopolysacharide-Induced Tumor Necrosis Factor-? Production in a Macrophage Subset.
Ontology highlight
ABSTRACT: In response to GM-CSF or M-CSF, macrophages (M?) can acquire pro- or anti-inflammatory properties, respectively. Given the importance of CD14 and Toll-like receptor (TLR) 4 in lipopolysaccharide (LPS)-induced signaling, we studied the effect of anti-CD14 antibody mediated CD14 blockade on LPS-induced cytokine production, signal transduction and on the expression levels of CD14 and TLR4 in GM-M? and M-M?. We found M-M? to express higher levels of both surface antigens and to produce more interferon (IFN)-? and interleukin-10, but less tumor necrosis factor (TNF)-? than GM-M?. Blockage of CD14 at high LPS concentrations increased the production of proinflammatory cytokines and decreased that of IFN-? in M-M? but not in GM-M?. We show that phosphorylation states of signaling molecules of the MyD88 (myeloid differentiation primary response 88), TRIF (TIR-domain-containing adapter-inducing IFN-?) and MAPK (mitogen-activated protein kinase) pathways are not altered in any way that would account for the cytokine overshoot reaction. However, CD14 blockage in M-M? decreased TLR4 and CD14 expression levels, regardless of the presence of LPS, indicating that the loss of the surface molecules prevented LPS from initiating TRIF signaling. As TNF-? synthesis was even upregulated under these experimental conditions, we suggest that TRIF is normally involved in restricting LPS-induced TNF-? overproduction. Thus, surface CD14 plays a decisive role in the biological response by determining LPS-induced signaling.
SUBMITTER: Grahnert A
PROVIDER: S-EPMC6738177 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA